Sign Up to like & get
recommendations!
1
Published in 2022 at "Advanced Materials"
DOI: 10.1002/adma.202203993
Abstract: Cancer‐targeting ligands used for nanomedicines have been limited mostly to antibodies, peptides, aptamers, and small molecules thus far. Here, a library of glycocalyx‐mimicking nanoparticles as a platform to enable screening and identification of cancer‐targeting nanomedicines…
read more here.
Keywords:
systematic screening;
therapeutic evaluation;
screening therapeutic;
cancer targeting ... See more keywords